These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1037223)
1. Study on the vasodilator effects of ethyl apovincaminate in neurosurgical patients. Fényes G; Tarjányi J; Ladvánszky C Arzneimittelforschung; 1976; 26(10a):1956-62. PubMed ID: 1037223 [TBL] [Abstract][Full Text] [Related]
2. Effect of ethyl apovincaminate on the cerebral circulation. Serial angiography and regional cerebral circulation studies in neurosurgical patients. Orosz E; Deák G; Benoist G Arzneimittelforschung; 1976; 26(10a):1951-6. PubMed ID: 798588 [TBL] [Abstract][Full Text] [Related]
3. Radiocirculographic study of the effect of ethyl apovincaminate on the cerebral circulation. Fényes S; Földes J Arzneimittelforschung; 1976; 26(10a):1963-4. PubMed ID: 798589 [TBL] [Abstract][Full Text] [Related]
4. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency. Hadjiev D; Yancheva S Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222 [TBL] [Abstract][Full Text] [Related]
5. Preliminary report on the use of ethyl apovincaminate in affections of the eyeground. Brooser G; Anda L; Domán J Arzneimittelforschung; 1976; 26(10a):1973-5. PubMed ID: 1037226 [TBL] [Abstract][Full Text] [Related]
6. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease. Solti F; Iskum M; Czakó E Arzneimittelforschung; 1976; 26(10a):1945-7. PubMed ID: 1037221 [TBL] [Abstract][Full Text] [Related]
7. Effect of ethyl apovincaminate on cerebral circulation of dogs under normal conditions and in arterial hypoxia. Bencsáth P; Debreczeni L; Takács L Arzneimittelforschung; 1976; 26(10a):1920-3. PubMed ID: 1037216 [TBL] [Abstract][Full Text] [Related]
8. The effect of ethyl apovincaminate on the circulation of the eyeground. Kahán A; Szabó M Arzneimittelforschung; 1976; 26(10a):1965-9. PubMed ID: 1037224 [TBL] [Abstract][Full Text] [Related]
9. Use of ethyl apovincaminate in ophthalmological therapy. Kahán A; Oláh M Arzneimittelforschung; 1976; 26(10a):1969-72. PubMed ID: 1037225 [TBL] [Abstract][Full Text] [Related]
10. Ethyl apovincaminate therapy in neurovascular diseases. Szobor A; Klein M Arzneimittelforschung; 1976; 26(10a):1984-9. PubMed ID: 1037230 [TBL] [Abstract][Full Text] [Related]
11. Effect of ethyl apovincaminate on cerebral, cardiac and renal flow rate in dogs in the course of administration. Szmolenszky T; Török B Arzneimittelforschung; 1976; 26(10a):1914-7. PubMed ID: 1037214 [TBL] [Abstract][Full Text] [Related]
12. Vasodilating effect of ethyl apovincaminate on conjunctival vessels and simultaneous observation of parameters indicating adverse effect. Brooser G; Anda L; Domán J Arzneimittelforschung; 1976; 26(10a):1975-7. PubMed ID: 1037227 [TBL] [Abstract][Full Text] [Related]
13. General and cerebral haemodynamic activity of ethyl apovincaminate. Kárpáti E; Szporny L Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212 [TBL] [Abstract][Full Text] [Related]
14. Effect of oral pretreatment with ethyl apovincaminate on the cardiac output and nutritive blood flow of various organs in rats. Debreczeni L; Takács L Arzneimittelforschung; 1976; 26(10a):1912. PubMed ID: 1037213 [TBL] [Abstract][Full Text] [Related]
15. Protective activity of ethyl apovincaminate on ischaemic anoxia of the brain. Biró K; Kárpáti E; Szporny L Arzneimittelforschung; 1976; 26(10a):1918-20. PubMed ID: 1037215 [TBL] [Abstract][Full Text] [Related]
16. [Use of cavinton in epilepsy]. Dutov AA; Tolpyshev BA; Petrov AP; Gladun VN Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):850-5. PubMed ID: 3751419 [TBL] [Abstract][Full Text] [Related]
17. Effects of ethyl apovincaminate on the central nervous system. Pálosi E; Szporny L Arzneimittelforschung; 1976; 26(10a):1926-9. PubMed ID: 1037217 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF. Vámosi B; Molnár L; Demeter J; Túry F Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229 [TBL] [Abstract][Full Text] [Related]
19. [10-year experience with using Cavinton in cerebrovascular disorders]. Burtsev EM; Savkov VS; Shprakh VV; Burtsev ME Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):56-60. PubMed ID: 1319651 [TBL] [Abstract][Full Text] [Related]
20. Summary of safety tests of ethyl apovincaminate. Cholnoky E; Dömök LI Arzneimittelforschung; 1976; 26(10a):1938-44. PubMed ID: 1037220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]